glp-1 agonists: Agonists - What is it? GLP-1 Receptor Agonists | New

These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk

Learn about their unique characteristics, benefits, side effec...

A complete guide for pharmacy and medical students preparing for exams.

Expanded uses in inflammatory bowel disease, neurological diseases, and metabolic dysfunction-associated steatohepatitis (MASH)

Weight Support*

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China